These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 36976496)

  • 1. Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias.
    Ozdemir H; Sagris D; Lip GYH; Abdul-Rahim AH
    Curr Cardiol Rep; 2023 May; 25(5):357-369. PubMed ID: 36976496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation.
    Tiili P; Leventis I; Kinnunen J; Svedjebäck I; Lehto M; Karagkiozi E; Sagris D; Ntaios G; Putaala J
    Ann Med; 2021 Dec; 53(1):1613-1620. PubMed ID: 34498537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulants for Asian patients with atrial fibrillation.
    Sabir I; Khavandi K; Brownrigg J; Camm AJ
    Nat Rev Cardiol; 2014 May; 11(5):290-303. PubMed ID: 24614113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.
    Plitt A; McGuire DK; Giugliano RP
    JAMA Cardiol; 2017 Apr; 2(4):442-448. PubMed ID: 28122078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation.
    Hammwöhner M; D'Alessandro A; Wolfram O; Goette A
    Curr Vasc Pharmacol; 2007 Jul; 5(3):211-9. PubMed ID: 17627564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation and Ischemic Stroke: A Clinical Review.
    Migdady I; Russman A; Buletko AB
    Semin Neurol; 2021 Aug; 41(4):348-364. PubMed ID: 33851396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
    Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
    J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review.
    Russo V; Bottino R; Rago A; Micco PD; D' Onofrio A; Liccardo B; Golino P; Nigro G
    Semin Thromb Hemost; 2019 Mar; 45(2):205-214. PubMed ID: 30119139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Renda G; Zimarino M; Ricci F; Piccini JP; Ezekowitz MD; Patel MR; Cappato R; Giugliano RP; De Caterina R
    Am J Med; 2016 Oct; 129(10):1117-1123.e2. PubMed ID: 27262782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis.
    Lee WC; Shih JY; Fang HY; Wu PJ; Fang CY; Chen HC; Fang YN; Chang WT; Chen MC
    Clin Appl Thromb Hemost; 2023; 29():10760296231158585. PubMed ID: 36815218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].
    De Caterina R; Renda G; Sangiuolo R; Attena E; Di Lecce L; Romeo F;
    G Ital Cardiol (Rome); 2014 Feb; 15(2):99-109. PubMed ID: 24625849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of anticoagulation management errors preceding ischaemic strokes in atrial fibrillation.
    Wong E; Aaqib M; Thijs V
    Intern Med J; 2022 Jun; 52(6):1024-1028. PubMed ID: 33346950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
    Hijazi Z; Wallentin L; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Pol T; Yusuf S; Oldgren J; Siegbahn A
    J Am Heart Assoc; 2020 Dec; 9(24):e018984. PubMed ID: 33292046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    van den Dries CJ; Pajouheshnia R; van den Ham HA; Souverein P; Moons KGM; Hoes AW; Geersing GJ; van Doorn S
    Br J Clin Pharmacol; 2023 Feb; 89(2):751-761. PubMed ID: 36102068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gray areas of oral anticoagulation for prevention of thromboembolic events in atrial fibrillation patients.
    Curcio A; Anselmino M; Di Biase L; Migliore F; Nigro G; Rapacciuolo A; Sergi D; Tomasi L; Pedrinelli R; Mercuro G; Filardi PP; Indolfi C;
    J Cardiovasc Med (Hagerstown); 2023 May; 24(Suppl 2):e97-e105. PubMed ID: 37186560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of thromboembolism in atrial fibrillation].
    Aguiar C
    Rev Port Cardiol; 2012 Apr; 31 Suppl 1():17-26. PubMed ID: 22541031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.